FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

E L E de Bruijne

Research Profile

Chemicals & Drugs

Procedures

Case Control Studies

Genes & Molecular Sequences

Single Nucleotide Polymorphism

Concepts & Ideas

Anatomy

Thrombosis

Physiology

Disorders

Co-author Network

Publications

TOP 3
Tamara N Bongers; E L E de Bruijne; Diederik W J Dippel; A J de Jong; Jaap Deckers; Don Poldermans; Moniek P M de Maat; Frank W G Leebeek
Lower levels of ADAMTS13 are associated with cardiovascular disease in young patients.
E L E de Bruijne; A Gils; Ana H C Guimarães; Diederik W J Dippel; Jaap Deckers; Anton H van den Meiracker; Don Poldermans; Dingeman C Rijken; P J Declerck; Moniek P M de Maat; Frank W G Leebeek
The role of thrombin activatable fibrinolysis inhibitor in arterial thrombosis at a young age: the ATTAC study.
Ana H C Guimarães; E L E de Bruijne; Ton Lisman; Diederik W J Dippel; Jaap W Deckers; Don Poldermans; Dingeman C Rijken; Frank W G Leebeek
Hypofibrinolysis is a risk factor for arterial thrombosis at young age.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of E L E de Bruijne (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Tamara N Bongers; E L E de Bruijne; Diederik W J Dippel; A J de Jong; Jaap Deckers; Don Poldermans; Moniek P M de Maat; Frank W G Leebeek
Lower levels of ADAMTS13 are associated with cardiovascular disease in young patients.
Atherosclerosis 2009;207(1):250-4.
2009: E L E de Bruijne; A Gils; Ana H C Guimarães; Diederik W J Dippel; Jaap Deckers; Anton H van den Meiracker; Don Poldermans; Dingeman C Rijken; P J Declerck; Moniek P M de Maat; Frank W G Leebeek
The role of thrombin activatable fibrinolysis inhibitor in arterial thrombosis at a young age: the ATTAC study.
Journal of thrombosis and haemostasis : JTH 2009;7(6):919-27.
2009: Ana H C Guimarães; E L E de Bruijne; Ton Lisman; Diederik W J Dippel; Jaap W Deckers; Don Poldermans; Dingeman C Rijken; Frank W G Leebeek
Hypofibrinolysis is a risk factor for arterial thrombosis at young age.
British journal of haematology 2009;145(1):115-20.
2008: Marieke Emonts; E L E de Bruijne; Ana H C Guimarães; P J Declerck; Frank W G Leebeek; Moniek P M de Maat; Dingeman C Rijken; Jan A Hazelzet; A Gils
Thrombin-activatable fibrinolysis inhibitor is associated with severity and outcome of severe meningococcal infection in children.
Journal of thrombosis and haemostasis : JTH 2008;6(2):268-76.
2007: E L E de Bruijne; Sarwa Darwish Murad; Moniek P M de Maat; Michael W T Tanck; Elizabeth B Haagsma; Bart van Hoek; Frits R Rosendaal; Harry L A Janssen; Frank W G Leebeek
Genetic variation in thrombin-activatable fibrinolysis inhibitor (TAFI) is associated with the risk of splanchnic vein thrombosis.
Thrombosis and haemostasis 2007;97(2):181-5.
2006: C H Martini; A Brandts; E L E de Bruijne; Astrid Van Hylckama Vlieg; Frank W G Leebeek; Ton Lisman; Frits R Rosendaal
The effect of genetic variants in the thrombin activatable fibrinolysis inhibitor (TAFI) gene on TAFI-antigen levels, clot lysis time and the risk of venous thrombosis.
British journal of haematology 2006;134(1):92-4.
2005: E L E de Bruijne; J P J Burgmans; Gabriel P Krestin; Huibert A P Pols; Anton H van den Meiracker; Wouter W de Herder
[Adrenal incidentaloma: a clinical problem related to imaging].
Nederlands tijdschrift voor geneeskunde 2005;149(33):1821-6.